Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07807033 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Observation of Immune Persistence in a Clinical Trial of an Adsorbed Tetanus Vaccine

StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study included 240 trial participants who had previously taken part in a Phase III clinical trial of an adsorbed tetanus vaccine (Protocol No.: CTP-TTVA-001), with 120 participants in each of the treatment and control groups. All trial participants were required to provide 3.0-4.0 mL of blood for an immunodurability assessment 2.5 years after vaccination.
Trial Details
NCT Number NCT07807033
Lead Sponsor CanSino Biologics Inc.
Conditions
(from sponsor)		 Tetanus
Related terms Tetanus
Enrollment 240 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov